| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.13 | 7e-05 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.13 | 8e-05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.21 | 9e-05 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0003 |